Precision Prediction in Healthcare: The New Vista for Leaders
Discover how longitudinal EHR data, genomic insights, and proteomics are shifting healthcare from reactive disease treatment to predictive risk management.
From Reactive Medicine to Predictive Healthcare: How AI Is Reshaping Healthy Longevity
AI is helping healthcare move from reactive treatment to predictive prevention. Discover how predictive analytics, biomarkers and personalised insights could reshape healthy longevity and the future of medicine.
Lifespan vs Healthspan: Which Should We Prioritise?
Lifespan vs healthspan: which should healthy longevity prioritise? A closer look at how this debate shapes research, clinical trials and public policy.
Why Healthy Longevity Clinics Struggle to Sustainably Scale — A Systems Perspective
Why do so many healthy longevity clinics struggle to achieve sustainable scale? Using a systems perspective and the 7S model, this article explores why success depends less on clinical intent and more on coherent organisational design.
The State of Healthy Longevity in 2026: Ten Wicked Issues Revisited
A clear-eyed review of healthy longevity at the close of 2025, revisiting ten wicked issues to assess progress, persistent gaps and what will shape the field’s trajectory in 2026 and beyond.
Guest Edition: ARDD 2025 - Big Pharma Discovers Healthy Longevity
At ARDD 2025, the world’s leading ageing-science conference, GLP-1 momentum and major pharma participation highlighted the accelerating shift toward healthy longevity. Key themes included gerotherapeutics, AI-driven breakthroughs, epigenetic clocks, and global clinical advances.
Call for Collaboration: Regulating the Future of Healthy Longevity Therapies
Richard Barker announced his new global working group on healthy longevity regulation during a major conference at the Lithuanian Parliament — a pivotal step in bridging innovation and policy.
Natural Therapies and Longevity Science: Towards a Healthier, Longer Life
Natural remedies and longevity science increasingly intersect. From herbs and adaptogens to lifestyle medicine, Richard Barker explores what natural therapies may contribute to a longer, healthier life.
Lithuania – from Healthspan Laggard to Leader?
How Lithuania is building a blueprint for healthy longevity — combining genomics, lifestyle medicine, and ageing science. A closer look at the country’s emerging healthspan initiatives and what they reveal about Europe’s evolving longevity landscape.
Dublin Longevity Summit 2025: 9 Surprising Insights That Could Redefine Healthy Aging
What do bats, nanobots, and voice patterns have in common? Each revealed surprising insights at the 2025 Longevity Summit Dublin. Richard Barker shares 9 standout ideas that could transform how we think about aging, from organ rejuvenation to AI-powered prevention.
Lisbon’s Longevity Summit: Lessons in Longevity Practicality
At Lisbon’s Longevity Med Summit, the message was clear: the future is already here. From biomarkers to breathwork, the tools for extending healthspan are no longer speculative — they’re practical, tested, and ready to use.
Inside Miami’s Longevity & Skincare Summit: A Look at the Future of Skin Health
At the Innocos Conference on Longevity in Skincare, I explored how biomarkers, AI, and regenerative medicine are shaping the future of skin health. With longevity-based skincare innovation on the rise, how do we balance scientific validation with industry growth? Read my key takeaways from Miami.
The Next Frontier in Longevity: Highlights from the Hevolution Summit 2025
The Hevolution Summit 2025 in Riyadh brought together global experts to discuss the future of longevity, investment, and healthcare innovation. With Saudi Arabia's Vision 2030 healthcare plan, could the Kingdom become a leader in biomarker-driven longevity regulation? Explore key insights from the event, including breakthroughs in biotech, investment trends, and the challenges ahead.
Biomarkers: The Key to Unlocking Healthy Longevity
Since measurable biomarkers are essential for tracking biological aging, assessing disease risk, and validating longevity interventions, they are shaping the future of healthcare. In this article, I explore the challenges of biomarker standardization, recent advances in proteomics, and how biomarker-driven regulation could transform aging research.
Bridging Gaps in Healthy Longevity: Insights from the JPMorgan Conference
The annual JPMorgan Health Conference provides a unique opportunity to gauge the state of life sciences and healthcare innovation. This year, key gaps in AI adoption and prevention-focused longevity therapies stood out, alongside promising discussions on advancing healthy aging. Discover insights from the event, the rise of GLP-1 therapies, and strategies to bridge critical gaps in longevity science.
End of 2024: Reflecting on Progress and Looking Ahead to 2025
A race against time: Reflecting on progress in healthy longevity and the urgent need for breakthroughs as we look ahead to 2025.
Uncovering Hidden Patterns: AI's Impact in Bogotá and London
Exploring the intersection of data and innovation: How AI uncovers hidden patterns in healthcare and beyond, from Bogotá to London.
Top 10 Wicked Issues in Healthy Longevity: Insights and Solutions
An in-depth review of the ten wicked issues shaping healthy longevity — from scientific gaps and biomarkers to regulation, reimbursement and public narrative — offering insight into the field’s biggest challenges and emerging solutions.
SPECIAL EDITION
A special edition top-down perspective on overcoming the top 10 wicked issues in healthy longevity, exploring high-level insights and strategic solutions across science, trials, regulation, reimbursement and systems integration.
GLP-1 Agonists: Our ChatGPT Moment in Preventive Medicine and Healthy Longevity
Discover how GLP-1 agonists, like Ozempic, are transforming preventive medicine and healthy longevity. Learn about their impact on weight loss, diabetes management, and reducing the risk of cardiovascular, kidney, and neurodegenerative diseases. Explore why this breakthrough is being hailed as our 'ChatGPT moment' in healthcare.